Figure 2From: Eligibility criteria for intraoperative radiotherapy for breast cancer: study employing 12,025 patients treated in two cohorts Survival without locoregional recurrence: patients of the G3S cohort not eligible for the TARGIT A study as a function of the HER2 status. Back to article page